148 related articles for article (PubMed ID: 32119131)
1. Mutational and transcriptomic landscapes of a rare human prostate basal cell carcinoma.
Su X; Long Q; Bo J; Shi Y; Zhao LN; Lin Y; Luo Q; Ghazanfar S; Zhang C; Liu Q; Wang L; He K; He J; Cui X; Yang JYH; Han ZG; Yang G; Sha JJ
Prostate; 2020 May; 80(6):508-517. PubMed ID: 32119131
[TBL] [Abstract][Full Text] [Related]
2. Genomic Characterization of Prostatic Basal Cell Carcinoma.
Low JY; Ko M; Hanratty B; Patel RA; Bhamidipati A; Heaphy CM; Sayar E; Lee JK; Li S; De Marzo AM; Nelson WG; Gupta A; Yegnasubramanian S; Ha G; Epstein JI; Haffner MC
Am J Pathol; 2023 Jan; 193(1):4-10. PubMed ID: 36309102
[TBL] [Abstract][Full Text] [Related]
3. Prostate epithelial genes define therapy-relevant prostate cancer molecular subtype.
Han H; Lee HH; Choi K; Moon YJ; Heo JE; Ham WS; Jang WS; Rha KH; Cho NH; Giancotti FG; Choi YD
Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1080-1092. PubMed ID: 33903734
[TBL] [Abstract][Full Text] [Related]
4. Molecular classification of basal cell carcinoma of skin by gene expression profiling.
Jee BA; Lim H; Kwon SM; Jo Y; Park MC; Lee IJ; Woo HG
Mol Carcinog; 2015 Dec; 54(12):1605-12. PubMed ID: 25328065
[TBL] [Abstract][Full Text] [Related]
5. Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection.
Gregg JL; Brown KE; Mintz EM; Piontkivska H; Fraizer GC
BMC Cancer; 2010 Apr; 10():165. PubMed ID: 20426842
[TBL] [Abstract][Full Text] [Related]
6. Genome-Wide Expression Difference of MicroRNAs in Basal Cell Carcinoma.
Wei HP; Zhan S; Zhu QA; Chen ZJ; Feng X; Chen JY; Zhang QL; Zhao J; Meng L
J Immunol Res; 2021; 2021():7223500. PubMed ID: 34395634
[TBL] [Abstract][Full Text] [Related]
7. ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63.
Torres A; Alshalalfa M; Davicioni E; Gupta A; Yegnasubramanian S; Wheelan SJ; Epstein JI; De Marzo AM; Lotan TL
Prostate; 2018 Sep; 78(12):896-904. PubMed ID: 29761525
[TBL] [Abstract][Full Text] [Related]
8. Basal cell carcinoma of the prostate: unusual subtype of prostatic carcinoma.
Komura K; Inamoto T; Tsuji M; Ibuki N; Koyama K; Ubai T; Azuma H; Katsuoka Y
Int J Clin Oncol; 2010 Dec; 15(6):594-600. PubMed ID: 20422244
[TBL] [Abstract][Full Text] [Related]
9. Spatial Intratumor Genomic Heterogeneity within Localized Prostate Cancer Revealed by Single-nucleus Sequencing.
Su F; Zhang W; Zhang D; Zhang Y; Pang C; Huang Y; Wang M; Cui L; He L; Zhang J; Zou L; Zhang J; Li W; Li L; Shao J; Ma J; Xiao F; Liu M
Eur Urol; 2018 Nov; 74(5):551-559. PubMed ID: 29941308
[TBL] [Abstract][Full Text] [Related]
10. Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens.
Browne TJ; Hirsch MS; Brodsky G; Welch WR; Loda MF; Rubin MA
Hum Pathol; 2004 Dec; 35(12):1462-8. PubMed ID: 15619204
[TBL] [Abstract][Full Text] [Related]
11. Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer.
Dong B; Miao J; Wang Y; Luo W; Ji Z; Lai H; Zhang M; Cheng X; Wang J; Fang Y; Zhu HH; Chua CW; Fan L; Zhu Y; Pan J; Wang J; Xue W; Gao WQ
Commun Biol; 2020 Dec; 3(1):778. PubMed ID: 33328604
[TBL] [Abstract][Full Text] [Related]
12. Conditionally reprogrammed normal and primary tumor prostate epithelial cells: a novel patient-derived cell model for studies of human prostate cancer.
Timofeeva OA; Palechor-Ceron N; Li G; Yuan H; Krawczyk E; Zhong X; Liu G; Upadhyay G; Dakic A; Yu S; Fang S; Choudhury S; Zhang X; Ju A; Lee MS; Dan HC; Ji Y; Hou Y; Zheng YL; Albanese C; Rhim J; Schlegel R; Dritschilo A; Liu X
Oncotarget; 2017 Apr; 8(14):22741-22758. PubMed ID: 28009986
[TBL] [Abstract][Full Text] [Related]
13. Combined genome and transcriptome analysis of single disseminated cancer cells from bone marrow of prostate cancer patients reveals unexpected transcriptomes.
Gužvić M; Braun B; Ganzer R; Burger M; Nerlich M; Winkler S; Werner-Klein M; Czyż ZT; Polzer B; Klein CA
Cancer Res; 2014 Dec; 74(24):7383-94. PubMed ID: 25320011
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation.
Sneddon JB; Zhen HH; Montgomery K; van de Rijn M; Tward AD; West R; Gladstone H; Chang HY; Morganroth GS; Oro AE; Brown PO
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14842-7. PubMed ID: 17003113
[TBL] [Abstract][Full Text] [Related]
15. Loss-of-Function Variants in the Tumor-Suppressor Gene
Olafsdottir T; Stacey SN; Sveinbjornsson G; Thorleifsson G; Norland K; Sigurgeirsson B; Thorisdottir K; Kristjansson AK; Tryggvadottir L; Sarin KY; Benediktsson R; Jonasson JG; Sigurdsson A; Jonasdottir A; Kristmundsdottir S; Jonsson H; Gylfason A; Oddsson A; Fridriksdottir R; Gudjonsson SA; Zink F; Lund SH; Rognvaldsson S; Melsted P; Steinthorsdottir V; Gudmundsson J; Mikaelsdottir E; Olason PI; Stefansdottir L; Eggertsson HP; Halldorsson BV; Thorsteinsdottir U; Agustsson TT; Olafsson K; Olafsson JH; Sulem P; Rafnar T; Gudbjartsson DF; Stefansson K
Cancer Res; 2021 Apr; 81(8):1954-1964. PubMed ID: 33602785
[TBL] [Abstract][Full Text] [Related]
16. Hedgehog Pathway Alterations Downstream of Patched-1 Are Common in Infundibulocystic Basal Cell Carcinoma.
Russell-Goldman E; MacConaill L; Hanna J
Am J Dermatopathol; 2021 Apr; 43(4):266-272. PubMed ID: 32796174
[TBL] [Abstract][Full Text] [Related]
17. Basal Cell Carcinoma of Prostate With MSMB-NCOA4 Fusion and a Probable Basal Cell Carcinoma In Situ: Case Report.
Pedersen V; Petersen KS; Brasso K; Østrup O; Loya AC
Int J Surg Pathol; 2021 Dec; 29(8):850-855. PubMed ID: 33978524
[TBL] [Abstract][Full Text] [Related]
18. Exploring multisite heterogeneity of human basal cell carcinoma proteome and transcriptome.
Berl A; Shir-Az O; Genish I; Biran H; Mann D; Singh A; Wise J; Kravtsov V; Kidron D; Golberg A; Vitkin E; Yakhini Z; Shalom A
PLoS One; 2023; 18(11):e0293744. PubMed ID: 37948379
[TBL] [Abstract][Full Text] [Related]
19. Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate.
Hansel DE; Nakayama M; Luo J; Abukhdeir AM; Park BH; Bieberich CJ; Hicks JL; Eisenberger M; Nelson WG; Mostwin JL; De Marzo AM
Prostate; 2009 May; 69(6):603-9. PubMed ID: 19125417
[TBL] [Abstract][Full Text] [Related]
20. [Basal cell carcinoma of prostate: a report of three cases].
Liu Z; Ma LL; Zhang SD; Lu M; Tian Y; He Q; Jin J
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):720-724. PubMed ID: 29263520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
